U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Over-the-Counter (OTC) Drugs
  6. Status of OTC Rulemakings
  7. Rulemaking History for OTC Antihistamine Drug Products
  1. Status of OTC Rulemakings

Rulemaking History for OTC Antihistamine Drug Products

Final Monograph (21 CFR part 341):
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use
 

OTC Antihistamine Drug Products found on this page:


Antihistamine Drug Products: Original Active Ingredients and Labeling
Advance Notice Of Proposed Rulemaking Date FR Citation
Advance Notice of Proposed Rulemaking [PDF] 9/9/1976 41FR38312
Reopening of Administrative Record [PDF] 3/21/1980 45FR18400
Proposed Rule Date FR Citation
Tentative Final Monograph [PDF] 1/15/1985 50FR2200
    Correction [PDF] 2/14/1985 50FR6199
    Correction [PDF] 3/6/1985 50FR9040
Proposed Rule: Classifies category II and III ingredients without data as nonmonograph [PDF] 5/16/1990 55FR20434
    Correction [PDF] 6/7/1990 55FR23235
Final Rule Date FR Citation
Final Rule: Classifies category II and III ingredients without data as nonmonograph [PDF] 11/7/1990 55FR46914
    Correction [PDF] 12/3/1990 55FR49973
    Technical Amendment: Correct an ingredient name [PDF] 1/30/1992 57FR3526
Final Monograph [PDF] 12/9/1992 57FR58356

Antihistamine Drug Products: Nonmonograph Ingredients
Proposed Rule Date FR Citation
Proposed Rule: Classifies category II and III ingredients without data as nonmonograph [PDF] 5/16/1990 55FR20434
    Correction [PDF] 6/7/1990 55FR23235
Final Rule Date FR Citation
Final Rule: Classifies category II and III ingredients without data as nonmonograph [PDF] 11/7/1990 55FR46914
    Correction [PDF] 12/3/1990 55FR49973
    Technical Amendment: Corrects an ingredient name [PDF] 1/30/1992 57FR3526

Antihistamine Drug Products: Chlorcyclizine HCl, Doxylamine Succinate, and Triprolidine HCl
Proposed Rule Date FR Citation
Proposed Rule [PDF] 8/24/1987 52FR31892
    Correction [PDF] 9/22/1987 52FR35610
Final Rule Date FR Citation
Final Rule [PDF] 1/28/1994 59FR4216
    Correction [PDF] 2/14/1997 62FR6866
 
Antihistamine Drug Products: Combination Products
Proposed Rule Date FR Citation
Proposed Rule [PDF] 8/12/1988 53FR30522
    Clarification: Promethazine HCl combinations [PDF] 11/14/1988 53FR45774
Proposed Rule: Diphenhydramine citrate and HCl combinations [PDF] 2/23/1995 60FR10286
Notice: Prohibits interim marketing of promethazine HCl combinations [PDF] 9/5/1989 54FR36762
Reopening of Administrative Record: Promethazine HCl combinations [PDF] 11/28/1989 54FR48914
    Correction [PDF] 1/4/1990 55FR310
    Extension of Comment Period [PDF] 1/24/1990 55FR2387
Final Rule Date FR Citation
Final Rule: Diphenhydramine citrate and HCl combinations [PDF] 4/9/1996 61FR15700
Final Rule [PDF] 12/23/2002 67FR78158
    Technical Amendment: Correction [PDF] 3/19/2007 72FR12730

Antihistamine Drug Products: Common Cold
Advance Notice Of Proposed Rulemaking Date FR Citation
Reopening of Administrative Record [PDF] 8/25/2000 65FR51780

Antihistamine Drug Products: Diphenhydramine Warnings
Proposed Rule Date FR Citation
Proposed Rule [PDF] 8/29/1997 62FR45767
Final Rule Date FR Citation
Final Rule [PDF] 12/6/2002 67FR72555

Antihistamine Drug Products: Phenylpropanolamine (PPA)
Advance Notice Of Proposed Rulemaking Date FR Citation
Notice: Advisory Committee meeting [PDF] 8/30/2000 65FR52775
Notice: Hearing on NDA withdrawal [PDF] 8/14/2001 66FR42665

Antihistamine Drug Products: Pediatric Use
Proposed Rule Date FR Citation
Notice: Advisory Committee Meeting [PDF] 8/16/2007 72FR46091
Notice of Public Hearing: Request for comments [PDF] 8/25/2008 73FR50033
Notice of Public Hearing: Correction [PDF] 9/2/2008 73FR51309